ANSON WILKS
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology PORTLAND, OR NPI 1275914426
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology OR Biogen, Inc. All categories
General Payments — all program years on this page
$1,107.27
- Category: General Payments
- Program years: PY2021–2024
- Record count: 15
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $688.25 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $421.29 | 5 |
| Education | $266.96 | 4 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $335.92 | 4 |
| ARGENX US, INC. | $145.46 | 2 |
| Sarepta Therapeutics, Inc. | $91.40 | 1 |
| Amicus Therapeutics, Inc. | $87.00 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $28.47 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104827218 | Biogen, Inc. | $62.50 | 07/03/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1104856092 | Biogen, Inc. | $97.43 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104867588 | Biogen, Inc. | $77.49 | 07/03/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1104876638 | Biogen, Inc. | $98.50 | 07/03/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1126540955 | Sarepta Therapeutics, Inc. | $91.40 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142118418 | ARGENX US, INC. | $62.12 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142119729 | ARGENX US, INC. | $83.34 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144510154 | MITSUBISHI TANABE PHARMA AMERICA, INC. | $28.47 | 02/02/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1148420521 | Amicus Therapeutics, Inc. | $87.00 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.